Laser treatment for diabetic eye disease and its effect on the cornea
Part of Eyes & vision clinical trials.
This trial tests whether a standard laser treatment for diabetic eye disease (called panretinal photocoagulation) affects the cells on the inside of the cornea, which is the clear front part of the eye. It may help doctors understand if this treatment is safe for your cornea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been newly diagnosed with proliferative diabetic retinopathy, a condition caused by diabetes that affects the blood vessels in the back of the eye.
- You need laser treatment (panretinal photocoagulation) for this condition.
- You have not had any previous eye surgery.
- You do not have any history of corneal disease, glaucoma, or inflammation inside the eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new laser treatment pattern for people with diabetic eye disease (proliferative diabetic retinopathy) to see if it works better than the standard approach. If you have this condition and want a less invasive treatment option, this study might be a good fit.
This study tests whether using a special eye scan (OCTA) to guide targeted laser treatment can slow down the progression of areas with poor blood flow in the retina of people with diabetic retinopathy. The goal is to prevent the condition from getting worse and help preserve your vision.
This study compares having laser treatment for diabetic eye disease in one session versus spreading it over multiple sessions. The goal is to find out if one approach is better for your eyes and easier for you.
This trial compares two treatments for early diabetic retinopathy—a condition where high blood sugar damages blood vessels in the eye. Researchers want to see if removing fluid from inside the eye (vitrectomy) works better than laser treatment to prevent vision loss.
This study looks at how well surgery called vitrectomy works for people with severe nonproliferative diabetic retinopathy (NPDR), a condition where high blood sugar damages the retina. The trial aims to see if this surgery can improve vision and outcomes.
This study compares two approaches to treat advanced diabetic eye disease (proliferative diabetic retinopathy): injections of faricimab plus laser, versus surgery (vitrectomy) with laser. It is for people with diabetes who need treatment for PDR and still have relatively good vision (20/100 or better) in the affected eye.
Hear when a new Panretinal Photocoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.